ReviewWorld journal of surgical oncology2025
Clinical characteristics and surgical management of rare thoracic myelolipoma: experience from a single center with literature review.
Review in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preperitoneal Myelolipoma Occurring after Video-Assisted Thoracoscopic Surgery for Thymoma: A Case Report.Surgical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundMyelolipoma is a rare benign tumor composed of mature adipose and hematopoietic tissue, most commonly occurring in the adrenal glands. Thoracic myelolipoma is extremely uncommon, particularly when originating in the lung or chest wall, and is frequently misdiagnosed due to its nonspecific clinical and radiological features. This study aimed to retrospectively characterize the clinical, imaging, pathological, and surgical features of thoracic myelolipoma and to conduct a comprehensive literature review to improve understanding of this rare entity.
methodsThirteen cases of thoracic myelolipoma diagnosed at Tongji Hospital between October 2015 and January 2025 were retrospectively reviewed. Data collected included patient demographics, clinical presentation, imaging characteristics, surgical approach, histopathology, and outcomes. Additionally, a comprehensive literature review was conducted using PubMed, Web of Science, and the Cochrane Library, covering reports published from 1960 to 2025. Descriptive statistics were used for data analysis.
resultsThirteen patients were included (mean age: 57.2 ± 8.0 years; 6 men). Nine patients (69.2%) presented with tumors in the posterior mediastinum, and four (30.8%) had tumors in the lung. Most lesions were well-circumscribed and incidentally detected. Eleven patients (84.6%) underwent uniportal video-assisted thoracoscopic surgery (VATS), and all cases were histopathologically confirmed as myelolipoma. No recurrence or metastasis was observed over a mean follow-up period of 40.5 ± 31.0 months. The literature review identified 71 additional cases with comparable clinical characteristics. Among the 33 patients with available follow-up, no recurrence or metastasis was reported.
conclusionsThoracic myelolipoma is a rare, indolent tumor that is often discovered incidentally and is generally associated with a favorable prognosis following complete surgical resection. VATS represents a minimally invasive and effective approach, offering both diagnostic and therapeutic benefits. Conservative observation may be appropriate for asymptomatic patients with characteristic imaging findings. However, surgical intervention is recommended when clinical symptoms are present or malignancy cannot be ruled out. Further large-scale studies with extended follow-up are warranted to refine management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.